It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...
Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...
Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...
Evidence of TME remodeling in patients treated with pharmacologically active doses is exemplified by increases in dendritic cells, M1 macrophages, plasma cells, and T follicular helper cells, as well ...
Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.04. Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear ...
Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, USA ...
This review explores the role of lysosomal stress in pancreatic diseases, particularly diabetes mellitus. Lysosomes, crucial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback